Cargando…
Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint
The only curative treatment for severe end-stage liver disease (ESLD) is liver transplantation (LT) but it is limited by the shortage of organ donors. The increase of the incidence of liver disease has led to develop new therapeutic approaches such as liver cell transplantation. Current challenges t...
Autores principales: | Pareja, Eugenia, Gómez-Lechón, M. José, Tolosa, Laia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347783/ https://www.ncbi.nlm.nih.gov/pubmed/32775367 http://dx.doi.org/10.21037/atm.2020.02.164 |
Ejemplares similares
-
Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
por: Grow, Douglas A., et al.
Publicado: (2016) -
Generation of Mice Derived from Induced Pluripotent Stem Cells
por: Boland, Michael J., et al.
Publicado: (2012) -
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020) -
Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects
por: Sheyn, Dmitriy, et al.
Publicado: (2016) -
Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions
por: Gandhi, Jarel K., et al.
Publicado: (2019)